Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06705452 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MRI Analysis in the Growth of Cerebral Aneurysms

Study acronym: EPICAVC
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 1 month later Jan 1, 2031 → Feb 7, 2032
See other at-risk trials from CHU de Reims

Record History

  1. Primary completion pushed from Jan 1, 2031 to Feb 7, 2032v2 Show 4 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Jan 1, 2025 to Jul 8, 2026
    • Study completion pushed from Jan 1, 2032 to Jul 8, 2032
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CHU de Reims
79 trials monitored
See 2 trials at risk
An intracranial aneurysm is defined as a localized dilatation of the cerebral arteries, which can potentially lead to rupture and subsequent hemorrhagic stroke. The mechanisms by which aneurysms develop and grow remain unknown. The objective of this project is to utilize MRI, a routine non-invasive examination for detecting and following up aneurysms, to identify visually and quantitatively an aneurysm growth and relevant biomarkers that can predict the risk of aneurysm development.
Trial Details
NCT Number NCT06705452
Lead Sponsor CHU de Reims
Conditions
(from sponsor)		 Unruptured Intracranial Aneurysm
Related terms Intracranial Aneurysm, Intracranial Arterial Diseases, Vascular Diseases
Enrollment 281 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov